National survey of doctor-reported secondary preventive treatment for patients with acute coronary syndrome in China.
BACKGROUND: Long-term use of antiplatelet agents, statins, beta-blockers and angiotensin-converting enzyme inhibitors are proven therapies for secondary prevention in acute coronary syndrome. However, little is known of physicians' opinion about their use in China. METHODS: In 2010, standard qu...
Huvudupphovsmän: | Li, J, Li, X, Chen, Y, Chen, Z, Zhang, L, Feng, F, Zhang, H, Liu, J, Gao, Y, Hundei, W, Li, L, Jiang, L |
---|---|
Materialtyp: | Journal article |
Språk: | English |
Publicerad: |
2013
|
Liknande verk
Liknande verk
-
Use of secondary preventive medications in patients with atherosclerotic disease in urban China: a cross-sectional study of 16, 860 patients.
av: Li, J, et al.
Publicerad: (2012) -
Underuse of statins in patients with atherosclerotic ischemic stroke in China.
av: Li, X, et al.
Publicerad: (2012) -
Effect of a quality of care improvement initiative in patients with acute coronary syndrome in resource-constrained hospitals in China
av: Wu, Y, et al.
Publicerad: (2019) -
[ACEI/ARB use among high risk patients with coronary heart disease in China: a cross-sectional study].
av: Liu, J, et al.
Publicerad: (2013) -
Proteomics of acute coronary syndromes.
av: Didangelos, A, et al.
Publicerad: (2009)